Drugwatch, run by a law firm, reports nearly 250 NAION cases in Pennsylvania federal court. Relkin, co-lead counsel in New Jersey, argues for an eye exam before starting a GLP-1.
Recap by typeshit. Full story at Drugwatch.com.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
Stavros Nicolaou of the Pharmaceutical Task Group wants police to act. SAHPRA says it has seized products and opened criminal cases.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
An eye doctor walks through the evidence on GLP-1 shots and vision, the rare warning signs to watch for and when to get urgent care.
Dr. Nisha Patel and Dr. Gillian Goddard walk through nine reasons, starting with dose. Even in STEP 1, nearly 14% on semaglutide lost under 5% of their weight.
Loading…